Lexpos News

/Lexpos News/

Improved prices for Indometacin 25mg capsules & Sumatriptan 50mg tablets for May 2026

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the May 2026 concessionary prices for Indometacin 25mg capsules & Sumatriptan 50mg tablets. Product Pack size Price concession Indometacin 25mg capsules 28 £11.20 (previously £10.24) Sumatriptan 50mg tablets 28 £6.26 (previously £5.85) [...]

The post Improved prices for Indometacin 25mg capsules & Sumatriptan 50mg tablets for May 2026 appeared first on Community Pharmacy England.

By |June 5th, 2026|Lexpos News|Comments Off on Improved prices for Indometacin 25mg capsules & Sumatriptan 50mg tablets for May 2026

NMS: Change to monthly cap from June 2026

Following the announcement of the 2026/27 negotiations, a Drug Tariff update has been published to base the New Medicine Service (NMS) monthly consultation cap on 0.9% rather than 1.0% of monthly prescriptions. This change is unlikely to impact the majority of pharmacy owners; however, pharmacy owners are encouraged to review the new caps, as shown [...]

The post NMS: Change to monthly cap from June 2026 appeared first on Community Pharmacy England.

By |June 5th, 2026|Lexpos News|Comments Off on NMS: Change to monthly cap from June 2026

Webinar recording: 2026/27 CPCF settlement

The post Webinar recording: 2026/27 CPCF settlement appeared first on Community Pharmacy England.

By |June 4th, 2026|Lexpos News|Comments Off on Webinar recording: 2026/27 CPCF settlement

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd)

MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) EL(26)A/27 DMRC reference number: DMRC- 39320587 Date issued: 4 June 2026 Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to [...]

The post MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd) appeared first on Community Pharmacy England.

By |June 4th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe (Teva UK Ltd)

PQS: CPPE asthma e-learning now available

The Centre for Pharmacy Postgraduate Education (CPPE) has now launched the Asthma for Pharmacy Quality Scheme 2026/27 e-learning. View the Asthma for Pharmacy Quality Scheme 2026/27 e-learning Pharmacists are required to complete this e-learning (as well as the Asthma e-assessment) by 31st March 2027 as part of the Medicines optimisation and patient safety domain of [...]

The post PQS: CPPE asthma e-learning now available appeared first on Community Pharmacy England.

By |June 4th, 2026|Lexpos News|Comments Off on PQS: CPPE asthma e-learning now available